Cargando…

Potential implications of practice effects in Alzheimer's disease prevention trials

INTRODUCTION: Practice effects (PEs) present a potential confound in clinical trials with cognitive outcomes. A single-blind placebo run-in design, with repeated cognitive outcome assessments before randomization to treatment, can minimize effects of practice on trial outcome. METHODS: We investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, Diane M., Ard, M. Colin, Salmon, David P., Galasko, Douglas R., Bondi, Mark W., Edland, Steven D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671629/ https://www.ncbi.nlm.nih.gov/pubmed/29124111 http://dx.doi.org/10.1016/j.trci.2017.08.010

Ejemplares similares

Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study
por: Edmonds, Emily C., et al.
Publicado: (2017)

Optimal composite scores for longitudinal clinical trials under the linear mixed effects model
por: Ard, M. Colin, et al.
Publicado: (2015)

Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research
por: Peavy, Guerry M., et al.
Publicado: (2020)

Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
por: Tsiknia, Amaryllis A., et al.
Publicado: (2022)

Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
por: Tsiknia, Amaryllis A., et al.
Publicado: (2022)

Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function
por: Sundermann, Erin E., et al.
Publicado: (2023)

Design of pilot studies to inform the construction of composite outcome measures
por: Edland, Steven D., et al.
Publicado: (2017)

Sex-specific composite scales for longitudinal studies of incipient Alzheimer’s disease
por: Banks, Sarah J., et al.
Publicado: (2019)

Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
por: Galasko, Douglas, et al.
Publicado: (2013)

Proof of concept demonstration of optimal composite MRI endpoints for clinical trials
por: Edland, Steven D., et al.
Publicado: (2016)

Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease‐related declines
por: Thomas, Kelsey R., et al.
Publicado: (2021)

Arterial stiffening acts synergistically with APOE genotype and AD biomarker status to influence memory in older adults without dementia
por: Bangen, Katherine J., et al.
Publicado: (2021)

NPTX2 and cognitive dysfunction in Alzheimer’s Disease
por: Xiao, Mei-Fang, et al.
Publicado: (2017)

Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches
por: Galasko, Douglas
Publicado: (2015)

United States medical students’ knowledge of Alzheimer disease
por: Nagle, Brian J., et al.
Publicado: (2013)

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
por: Galasko, Douglas, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Their Role in Clinical Chemistry
por: Blennow, Kaj, et al.
Publicado: (2000)

Recent Alzheimer's disease research highlights
por: Galasko, Douglas, et al.
Publicado: (2012)

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
por: Galasko, Douglas, et al.
Publicado: (2020)

A survey of smartphone and interactive video technology use by participants in Alzheimer's disease research: Implications for remote cognitive assessment
por: Jacobs, Diane M., et al.
Publicado: (2021)

Right sizing funding for Alzheimer's disease
por: Golde, Todd E, et al.
Publicado: (2011)

Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials
por: Andrews, K. Abigail, et al.
Publicado: (2013)

Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials
por: Aschenbrenner, Andrew J., et al.
Publicado: (2022)

Adherence/Retention Alzheimer's Prevention Initiative Colombia Plan
por: Rios-Romenets, Silvia, et al.
Publicado: (2018)

Progress in Alzheimer's disease research circa 2013: Is the glass half empty or half full?
por: Galasko, Douglas, et al.
Publicado: (2013)

Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer’s Disease Pathology(1)
por: Ryman, Sephira G., et al.
Publicado: (2021)

Impact of potential modifications to Alzheimer’s disease clinical trials in response to disruption by COVID-19: a simulation study
por: Schneider, Lon S., et al.
Publicado: (2021)

Cognitive Practice Effects Delay Diagnosis; Implications for Clinical Trials
por: Sanderson-Cimino, Mark, et al.
Publicado: (2020)

Elevated Norepinephrine Metabolism Gauges Alzheimer’s Disease-Related Pathology and Memory Decline
por: Riphagen, Joost M., et al.
Publicado: (2021)

Glioma and Alzheimer’s Disease
por: Lehrer, Steven
Publicado: (2018)

Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials
por: Sanderson‐Cimino, Mark, et al.
Publicado: (2022)

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
por: Smirnov, Denis S., et al.
Publicado: (2022)

Dedifferentiation and neuronal repression define familial Alzheimer’s disease
por: Caldwell, Andrew B., et al.
Publicado: (2020)

Cost‐effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price
por: Sinha, Pranay, et al.
Publicado: (2022)

Paediatric fracture clinic design – current practice and implications for change
por: Huntley, James S
Publicado: (2014)

The Italian Tamoxifen Prevention Trial
por: Bonanni, B., et al.
Publicado: (1999)

Welcome to Alzheimer's Research & Therapy
por: Donnelly, Ann, et al.
Publicado: (2009)

Clinical Course of Development of Alcohol and Opioid Dependence: What are the Implications in Prevention?
por: Saddichha, Sahoo, et al.
Publicado: (2010)

Controlled Neuronal Death during Aging Might Be an Attractive Therapeutic Target for Preventing Alzheimer's Disease
por: Schmitz, Christoph, et al.
Publicado: (2001)

The Multiple Lenses on the Community Health System: Implications for Policy, Practice and Research
por: Schneider, Helen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rf92pkp0lqtm7hvepa39h8fh1a